Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-003581
Filing Date
2020-04-03
Accepted
2020-04-02 19:23:32
Documents
113
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K jagx-20191231x10k.htm 10-K 4269707
2 EX-4.26 jagx-20191231ex426e78444.htm EX-4.26 21444
3 EX-10.101 jagx-20191231ex10101a436.htm EX-10.101 239160
4 EX-23.1 jagx-20191231ex231b9cde5.htm EX-23.1 3031
5 EX-23.2 jagx-20191231ex232e7a3ed.htm EX-23.2 6992
6 EX-31.1 jagx-20191231ex311163973.htm EX-31.1 12122
7 EX-31.2 jagx-20191231ex3120cb334.htm EX-31.2 12033
8 EX-32.1 jagx-20191231ex3212c9236.htm EX-32.1 6538
9 EX-32.2 jagx-20191231ex322bc710d.htm EX-32.2 7246
10 GRAPHIC jagx20191231x10k001.jpg GRAPHIC 23509
  Complete submission text file 0001558370-20-003581.txt   16536566

Data Files

Seq Description Document Type Size
11 EX-101.INS jagx-20191231.xml EX-101.INS 2893688
12 EX-101.SCH jagx-20191231.xsd EX-101.SCH 132420
13 EX-101.CAL jagx-20191231_cal.xml EX-101.CAL 77797
14 EX-101.DEF jagx-20191231_def.xml EX-101.DEF 711190
15 EX-101.LAB jagx-20191231_lab.xml EX-101.LAB 1021064
16 EX-101.PRE jagx-20191231_pre.xml EX-101.PRE 983792
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36714 | Film No.: 20771073
SIC: 2834 Pharmaceutical Preparations